“False positive” results of the estrogen receptor (ER) radioligand assay in breast cancer may be caused by immunocytochemically demonstrable ER in surrounding, non-malignant tissue
G.W. Locher, M. Gorgievski, E. WaeltiVolume:
28
Year:
1987
Language:
english
DOI:
10.1016/0022-4731(87)91103-4
File:
PDF, 142 KB
english, 1987